Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biopharmaceutical Companies 2024
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.
  1. Alector

    World Rank (Jan-05-2024)
    10,826
    Market Cap (Jan-05-2024)
    0.671 Billion USD
    World Rank (Jul-30-2023)
    12,352
    Market Cap (Jul-30-2023)
    0.531 Billion USD
    World Rank (Dec-25-2022)
    10,106
    Market Cap (Dec-25-2022)
    0.731 Billion USD
    World Rank (Jan-07-2022)
    7,536
    Market Cap (Jan-07-2022)
    1.46 Billion USD
    Annual Revenue in USD
    133 Million USD
    Annual Operating Income in USD
    -137 Million USD
    Annual Net Income in USD
    -133 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Alector is a Clinical Stage Biopharmaceutical company developing a broad portfolio of programs designed to empower the brains immune system to fight disease. It is having 78 employees as on 2019. The headquarters is in USA.
  2. Gongwin Biopharm Holdings

    World Rank (Jan-05-2024)
    10,853
    Market Cap (Jan-05-2024)
    0.667 Billion USD
    World Rank (Jul-30-2023)
    9,963
    Market Cap (Jul-30-2023)
    0.793 Billion USD
    World Rank (Dec-25-2022)
    3,761
    Market Cap (Dec-25-2022)
    3.360 Billion USD
    World Rank (Jan-07-2022)
    8,762
    Market Cap (Jan-07-2022)
    1.14 Billion USD
    Headquarters Country
    Company Profile
    Gongwin Biopharm Holdings is a clinical stage biopharmaceutical company focused on developing novel anti-cancer drugs. The headquarters is in Taiwan.
  3. Tarsus Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    10,892
    Market Cap (Jan-05-2024)
    0.662 Billion USD
    World Rank (Jul-30-2023)
    11,446
    Market Cap (Jul-30-2023)
    0.614 Billion USD
    World Rank (Dec-25-2022)
    14,096
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    13,834
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    26 Million USD
    Annual Operating Income in USD
    -63 Million USD
    Annual Net Income in USD
    -62 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Tarsus Pharmaceuticals is a Late Clinical Stage Biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent conditions with limited treatment options. It is having 20 employees as on 2019. The headquarters is in USA.
  4. Urovant Sciences

    World Rank (Jan-05-2024)
    11,036
    World Rank (Jul-30-2023)
    11,036
    World Rank (Dec-25-2022)
    11,036
    World Rank (Jan-07-2022)
    11,036
    Headquarters Country
    Company Profile
    Urovant Sciences is a Biopharmaceutical company focused on developing and commercializing innovative therapies for a range of urologic conditions. The company estimated annual revenue is currently 39.2 million USD per year. The headquarters is in USA.
  5. Fusion Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    11,376
    Market Cap (Jan-05-2024)
    0.611 Billion USD
    World Rank (Jul-30-2023)
    17,315
    Market Cap (Jul-30-2023)
    0.229 Billion USD
    World Rank (Dec-25-2022)
    19,740
    Market Cap (Dec-25-2022)
    0.145 Billion USD
    World Rank (Jan-07-2022)
    18,656
    Market Cap (Jan-07-2022)
    0.21 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Fusion Pharmaceuticals does research and works on Next-Generation Radiopharmaceuticals for precision medicine. Headquarters is in Canada.
  6. Adagio Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,720
    World Rank (Jul-30-2023)
    11,720
    World Rank (Dec-25-2022)
    11,720
    World Rank (Jan-07-2022)
    11,720
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -226 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  7. AN2 Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,747
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    19,243
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    18,440
    Market Cap (Dec-25-2022)
    0.185 Billion USD
    World Rank (Jan-07-2022)
    16,213
    Headquarters Country
    Company Profile

    AN2 Therapeutics, Inc is a biopharmaceutical company develops therapeutics to treat rare, chronic and serious infectious diseases in areas of high unmet medical need. The headquarters is in United States.

  8. Marinus Pharmaceuticals

    World Rank (Jan-05-2024)
    11,762
    Market Cap (Jan-05-2024)
    0.574 Billion USD
    World Rank (Jul-30-2023)
    12,607
    Market Cap (Jul-30-2023)
    0.512 Billion USD
    World Rank (Dec-25-2022)
    18,773
    Market Cap (Dec-25-2022)
    0.174 Billion USD
    World Rank (Jan-07-2022)
    14,722
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    25 Million USD
    Annual Operating Income in USD
    -112 Million USD
    Annual Net Income in USD
    -20 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Marinus Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an investigational drug, ganaxolone which is an innovative and much needed potential treatment option for children and adults. The company annual revenue is 1.72 million USD and 82 employees as on 2020. The headquarters is in USA.
  9. Anavex Life Sciences

    World Rank (Jan-05-2024)
    12,167
    Market Cap (Jan-05-2024)
    0.536 Billion USD
    World Rank (Jul-30-2023)
    11,175
    Market Cap (Jul-30-2023)
    0.641 Billion USD
    World Rank (Dec-25-2022)
    10,700
    Market Cap (Dec-25-2022)
    0.659 Billion USD
    World Rank (Jan-07-2022)
    8,577
    Market Cap (Jan-07-2022)
    1.18 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -51 Million USD
    Annual Net Income in USD
    -48 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    Company Profile
    Anavex Life Sciences is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments. The headquarters is in USA.

Share

Ads